A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.
- Heather L. McArthur
- , David B Page
- , See full list of authors in comments
Research output: Other contribution